Theratechnologies Inc.

Rentabilité sur six mois: +45.45%
Rendement en dividendes: 0%
Secteur: Healthcare

2.48 $

0 $ 0%
1.17 $
2.92 $

paper.min_max_per_year

Calendrier des promotions Theratechnologies Inc.

À propos de l'entreprise Theratechnologies Inc.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

Paramètres de base

IPO date
2016-01-04
ISIN
CA88338H1001
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 0.6898 10
P/BV -2.34 0
P/E 0 0
Efficacité
Nom Signification Grade
ROA -12.67 0
ROE 36 9
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA 6.63 0
Debt/Ratio 0.855 9
Debt/Equity -3.11 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 29.9 4
Rentabilité Ebitda, % -174.77 0
Rentabilité EPS, % -42.84 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 2.48 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 2.58 $ 0 $ 0 $ -3.88 % 0 % 0 %
common.calendar.number_days.30d 2.64 $ 2.48 $ 2.6 $ -6.06 % 0 % 0 %
common.calendar.number_days.90d 1.94 $ 1.33 $ 2.92 $ 27.84 % 0 % 0 %
common.calendar.number_days.180d 1.71 $ 1.33 $ 2.92 $ 45.45 % 0 % 0 %
common.calendar.number_days.1y 1.29 $ 1.17 $ 2.92 $ 93 % 0 % 0 %
common.calendar.number_days.3y 8.6 $ 0.89 $ 9.68 $ -71.16 % 0 % 0 %
common.calendar.number_days.5y 2.44 $ 0.89 $ 9.68 $ 1.64 % 0 % 0 %
common.calendar.number_days.10y 0.89 $ 0.89 $ 11.24 $ 278.65 % 0 % 0 %
common.calendar.number_days.ytd 1.44 $ 1.33 $ 2.92 $ 72.22 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Paul Lévesque President, CEO & Director 1.18M 1964 (61 année)
Mr. Philippe Dubuc M.B.A., MBA Senior VP & CFO 432.31k 1967 (58 années)
Mr. Jocelyn Lafond L.L.M., LL.B. General Counsel & Corporate Secretary 316.29k 1968 (57 années)
Dr. Christian Marsolais Ph.D. Senior VP & Chief Medical Officer 434.61k 1963 (62 année)
Mr. John Leasure Global Commercial Officer 420.91k 1965 (60 années)
Hon. Andre Dupras M.Sc. Vice President of Human Resources N/A 1964 (61 année)

Informations sur l'entreprise

Adresse: Canada, Montreal. QC HA T, 2015 Peel Street - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.theratech.com